Bioactive peptides in cereals and legumes: Agronomical, biochemical and clinical aspects

International Journal of Molecular Sciences

Volumn 15, Issue 11, 2014, Pages 21120-21135

  Malaguti, Marco ^a   Dinelli, Giovanni ^a   Leoncini, Emanuela ^a   Bregola, Valeria ^a   Bosi, Sara ^a   Cicero, Arrigo F G ^a   Hrelia, Silvana ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Agronomical aspects; Bioactive peptides; Biological activities; Cereals; Clinical aspects; Legumes

Indexed keywords

CHYMOTRYPSIN; LECTIN; NUTRACEUTICAL; TRYPSIN; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CARDIOVASCULAR AGENT; PEPTIDE;

AGRONOMY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; BIOAVAILABILITY; BIOLOGICAL ACTIVITY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CEREAL; CHOLESTEROL INTAKE; CROP MANAGEMENT; ELECTROSPRAY MASS SPECTROMETRY; ENVIRONMENTAL TEMPERATURE; GROWTH REGULATION; IMMUNOASSAY; IMMUNOMODULATION; LEGUME; LIQUID CHROMATOGRAPHY; MEDITERRANEAN DIET; MINERAL METABOLISM; NONHUMAN; PLANT BREEDING; PROTEIN HYDROLYSIS; REVIEW; SOIL MOISTURE; ANIMAL; CHEMISTRY; CLINICAL TRIAL (TOPIC); FABACEAE; HUMAN; ISOLATION AND PURIFICATION; NEOPLASMS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CARDIOVASCULAR AGENTS; CLINICAL TRIALS AS TOPIC; EDIBLE GRAIN; FABACEAE; HUMANS; NEOPLASMS; PEPTIDES;

EID: 84910123375     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151121120     Document Type: Review

References (87)

1. Farrokhi, N.; Whitelegge, J.P.; Brusslan, J.A. Plant peptides and peptidomics. Plant Biotechnol. J. 2008, 6, 105-134.
2. Coda, R.; Rizzello, C.G.; Pinto, D.; Gobbetti, M. Selected lactic acid bacteria synthesize antioxidant peptides during sourdough fermentation of cereal flours. Appl. Environ. Microbiol. 2012, 78, 1087-1096.
3. Zambrowicz, A.; Timmer, M.; Polanowski, A.; Lubec, G.; Trziszka, T. Manufacturing of peptides exhibiting biological activity. Amino Acids 2013, 44, 315-320.
4. Belovic, M.M.; Mastilović, J.S.; Torbica, A.L.; Tomić, J.M.; Stanić, D.R.; Džinić, N.R. Potential of bioactive proteins and peptides for prevention and treatment of mass non-communicable dieseases. Food Feed Res. 2011, 38, 51-61.
5. Ortiz-Martinez, M.; Winkler, R.; Garcia-Lara, S. Preventive and therapeutic potential of peptides from cereals against cancer. J. Proteomics 2014, doi:10.1016/j.jprot.2014.03.044.
6. Jeong, H.J.; Jeong, J.B.; Hsieh, C.C.; Hernandez-Ledesma, B.; de Lumen, B.O. Lunasin is prevalent in barley and is bioavailable and bioactive in vivo and in vitro studies. Nutr. Cancer 2010, 62, 1113-1119.
7. Jeong, H.J.; Jeong, J.B.; Kim, D.S.; Park, J.H.; Lee, J.B.; Kweon, D.H.; Chung, G.Y.; Seo, E.W.; de Lumen, B.O. The cancer preventive peptide lunasin from wheat inhibits core histone acetylation. Cancer Lett. 2007, 255, 42-48.
8. Jeong, H.J.; Lee, J.R.; Jeong, J.B.; Park J.H.; Cheong, Y.K.; de Lumen, B.O. The preventive seed peptide lunasin from rye is bioavailable and bioactive. Nutr. Cancer 2009, 61, 680-686.
9. Park, J.H.; Jeong, H.J.; de Lumen, B.O. Contents and bioactivities of lunasin, bowman-birk inhibitor, and isoflavones in soybean seed. J. Agric. Food Chem. 2005, 53, 7686-7690.
10. Hernandez-Ledesma, B.; Hsieh, C.C.; de Lumen, B.O. Chemopreventive properties of peptide lunasin: A review. Protein Pept. Lett. 2013, 20, 424-432.
11. Dinelli, G.; Bregola, V.; Bosi, S.; Fiori, J.; Gotti, R.; Simonetti, E.; Trozzi, C.; Leoncini, E.; Prata, C.; Massaccesi, L., et al. Lunasin in wheat: A chemical and molecular study on its presence or absence. Food Chem. 2014, 151, 520-525.
12. De Mejia, E.G.; Vásconez, M.; de Lumen, B.O.; Nelson, R. Lunasin concentration in different soybean genotypes, commercial soy protein, and isoflavone products. J. Agric. Food Chem. 2004, 52, 5882-5887.
13. Hernandez-Ledesma, B.; Hsieh, C.C.; de Lumen, B.O. Lunasin, a novel seed peptide for cancer prevention. Peptides 2009, 30, 426-430.
14. Chan, Y.S.; Zhang, Y.; Ng, T.B. Brown Kidney Bean Bowman-Birk Trypsin Inhibitor is Heat and pH Stable and Exhibits Anti-Proliferative Activity. Appl. Biochem. Biotechnol. 2013, 169, 1306-1314.
15. De Mejia, E.G.; Dia, V.P. The role of nutraceutical proteins and peptides in apoptosis, angiogenesis, and metastasis of cancer cells. Cancer Metastasis Rev. 2010, 29, 511-528.
16. Domagalski, J.M.; Kollipara, K.P.; Bates, A.H.; Brandon, D.L.; Friedman, M.; Hymowitz, T. Nulls for the major soybean Bowman-Birk protease inhibitor in the genus Glycine. Crop Sci. 1992, 32, 1502-1505.
17. Pesic, M.; Vucelic-RAdovic, B.V.; Barac, M.B.; Stanojevic, S.P.; Nedovic, V.A. Influence of different genotypes on trypsin inhibitor levels and activity in soybeans. Sensors 2007, 7, 67-74.
18. Krishnan H.B.; Jang, S.; Baxter, I.; Wiebold, W. Growing location has a pronounced effect on the accumulation of cancer chemopreventive agent Bowman-Birk inhibitor in soybean seeds. Crop Sci. 2012, 52, 1786-1794.
19. Galvez, A.F.; de Lumen, B.O. A soybean cDNA encoding a chromatin-binding peptide inhibits mitosis of mammalian cells. Nat. Biotechnol. 1999, 17, 495-500.
20. Galvez, A.F.; Chen, N.; Macasieb, J.; de Lumen, B.O. Chemopreventive property of a soybean peptide (lunasin) that binds to deacetylated histones and inhibits acetylation. Cancer Res. 2001, 61, 7473-7478.
21. Lam, A.F.; Galvez, A.; de Lumen, B.O. Lunasin suppresses E1A-mediated transformation of mammalian cells but does not inhibit growth of immortalized and established cancer cell lines. Nutr. Cancer 2003, 47, 88-94.
22. Jeong, H.J.; Lam, Y.; de Lumen, B.O. Barley lunasin suppresses ras-induced colony formation and inhibits core histone acetylation in mammalian cells. J. Agric. Food Chem. 2002, 50, 5903-5908.
23. Jeong, H.J.; Park, J.H.; Lam, Y.; de Lumen, B.O. Characterization of lunasin isolated from soybean. J. Agric. Food Chem. 2003, 51, 7901-7906.
24. De Mejia, E.G.; Wang, W.; Dia, V.P. Lunasin, with an arginine-glycine-aspartic acid motif, causes apoptosis to L1210 leukemia cells by activation of caspase-3. Mol. Nutr. Food Res. 2010, 54, 406-414.
25. Dia, V.P.; Mejia, E.G. Lunasin promotes apoptosis in human colon cancer cells by mitochondrial pathway activation and induction of nuclear clusterin expression. Cancer Lett. 2010, 295, 44-53.
26. Kannan, A.; Hettiarachchy, N.S.; Lay, J.O.; Liyanage, R. Human cancer cell proliferation inhibition by a pentapeptide isolated and characterized from rice bran. Peptides 2010, 31, 1629-1634.
27. Souza Lda, C.; Camargo, R.; Demasi, M.; Santana, J.M.; de Sá, C.M.; de Freitas, S.M. Effects of an anticarcinogenic Bowman-Birk protease inhibitor on purified 20S proteasome and MCF-7 breast cancer cells. PLoS One 2014, 9, e86600.
28. Chen, Y.W.; Huang, S.C.; Lin-Shiau, S.Y.; Lin, J.K. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1. Carcinogenesis 2005, 26, 1296-1306.
29. Saito, T.; Sato, H.; Virgona, N.; Hagiwara, H.; Kashiwagi, K.; Suzuki, K.; Asano, R.; Yano, T. Negative growth control of osteosarcoma cell by Bowman-Birk protease inhibitor from soybean; involvement of connexin 43. Cancer Lett. 2007, 253, 249-257.
30. Suzuki, K.; Yano, T.; Sadzuka, Y.; Sugiyama, T.; Seki, T.; Asano, R. Restoration of connexin 43 by Bowman-Birk protease inhibitor in M5076 bearing mice. Oncol. Rep. 2005, 13, 1247-1250.
31. Richardson, P.G.; Mitsiades, C.; Hideshima, T.; Anderson, K.C. Bortezomib: Proteasome inhibition as an effective anticancer therapy. Future Oncol. 2005, 1, 161-171.
32. An, B.; Goldfarb, R.H.; Siman, R.; Dou1, Q.P. Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts. Cell. Death Differ. 1998, 5, 1062-1075.
33. Voorhees, P.M.; Dees, E.C.; O’Neil, B.; Orlowski, R.Z. The proteasome as a target for cancer therapy. Clin. Cancer Res. 2003, 9, 6316-6325.
34. Hsieh, C.C.; Hernández-Ledesma, B.; Jeong, H.J.; Park, J.H., de Lumen, B.O. Complementary roles in cancer prevention: Protease inhibitor makes the cancer preventive peptide lunasin bioavailable. PLoS One 2010, 5, e8890.
35. Wang, Q.; Yu, L.G.; Campbell, B.J.; Milton, J.D.; Rhodes, J.M. Identification of intact peanut lectin in peripheral venous blood. Lancet 1998, 352, 1831-1832.
36. Goldstein, I.J.; Winter, H.C.; Mo, H.; Misaki, A.; van Damme, E.J.; Peumans, W.J. Carbohydrate binding properties of banana (Musa acuminata) lectin II. Binding of laminaribiose oligosaccharides and beta-glucans containing β1,6-glucosyl end groups. Eur. J. Biochem. 2001, 268, 2616-2619.
37. Vasconcelos, I.M.; Siebra, E.A.; Maia, A.A.B.; Moreira, R.A.; Neto, A.F.; Campelo, G.J.A.; Oliveira, J.T.A. Composition, toxic, and anti-nutritional factorsof newly developed cultivars of Brazilian soybean (Glycine max). J. Food Sci. Agric. 1997, 75, 419-426.
38. Liener, I.E. From soybeans to lectins: A trail of research revisited. Carbohydr. Res. 1991, 213, 1-5.
39. Boland, C.R.; Martin, M.A.; Goldstein, I.J. Lectin reactivities as intermediate biomarkers in premalignant colorectal epithelium. J. Cell. Biochem. Suppl. 1992, 16G, 103-109.
40. Garcia-Gasca, T.; García-Cruz, M.; Hernandez-Rivera, E.; López-Matínez, J.; Castañeda-Cuevas, A.L.; Yllescas-Gasca, L.; Rodríguez-Méndez, A.J.; Mendiola-Olaya, E.; Castro-Guillén, J.L.; Blanco-Labra, A., et al. Effects of Tepary bean (Phaseolus acutifolius) protease inhibitor and semipure lectin fractions on cancer cells. Nutr. Cancer 2012, 64, 1269-1278.
41. Dia, V.P.; Wang, W.; Oh, V.L.; de Lumen, B.O.; de Meja, E.G. Isolation, purification and characterization of lunasin from defatted soybean flour and in vitro evaluation of its antinflammatory activity. Food Chem. 2009, 114, 108-115.
42. Hernandez-Ledesma, B.; Hsieh, C.C.; de Lumen, B.O. Antioxidant and anti-inflammatory properties of cancer preventive peptide lunasin in RAW 264.7 macrophages. Biochem. Biophys. Res. Commun. 2009, 390, 803-808.
43. Cam, A.; de Mejia, E.G. RGD-peptide lunasin inhibits Akt-mediated NF-κB activation in human macrophages through interaction with the αVβ3 integrin. Mol. Nutr. Food Res. 2012, 56, 1569-1581.
44. Aguzzi, M.S.; Fortugno, P.; Giampietri, C.; Ragone, G.; Capogrossi, M.C.; Facchiano, A. Intracellular targets of RGDS peptide in melanoma cells. Mol. Cancer 2010, 9, 84-94.
45. Calhoun, D.A.; Jones, D.; Textor, S.; Goff, D.C.; Murphy, T.P.; Toto, R.D.; White, A.; Cushman, W.C.; White, W.; Sica, D., et al. Resistant hypertension: Diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008, 51, 1403-1419.
46. Lenz, T.L.; Monaghan, M.S. Lifestyle modifications for patients with hypertension. J. Am. Pharm. Assoc. 2008, 48, e92-e102.
47. Leoncini, E.; Prata, C.; Malaguti, M.; Marotti, I.; Segura-Carretero, A.; Catizone, P.; Dinelli, G.; Hrelia, S. Phytochemical profile and nutraceutical value of old and modern common wheat cultivars. PLoS One 2012, 7, e45997.
48. Aoyagi, Y. An angiotensin-I converting enzyme inhibitor from buckwheat (Fagopyrum esculentum Moench) flour. Phytochemistry 2006, 67, 618-621.
49. Huang, W.Y.; Davidge, S.T.; Wu, J. Bioactive natural constituents from food sources-potential use in hypertension prevention and treatment. Crit. Rev. Food Sci. Nutr. 2013, 53, 615-630.
50. Kwon, Y.I.; Apostolidis, E.; Kim, Y.C.; Shetty, K. Health benefits of traditional corn, beans, and pumpkin: In vitro studies for hyperglycemia and hypertension management. J. Med. Food 2007, 10, 266-275.
51. Rizzello, C.G.; Cassone, A.; di Cagno, R.; Gobbetti, M. Synthesis of angiotensin I-converting enzyme (ACE)-inhibitory peptides and γ-aminobutyric acid (GABA) during sourdough fermentation by selected lactic acid bacteria. J. Agric. Food Chem. 2008, 56, 6936-6943.
52. Matsui, T.; Li, C.H.; Osajima, Y. Preparation and characterization of novelbioactive peptides responsible for angiotensin I-converting enzymes from wheat germ. J. Pept. Sci. 1999, 5, 289-297.
53. Motoi, H.; Kodama, T. Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides from wheat gliadin hydrolysate. Nahrung 2003, 47, 354-358.
54. Li, G.H.; Qu, M.R.; Wan, J.Z.; You, J.M. Antihypertensive effect of rice protein hydrolysate with in vitro angiotensin I-converting enzyme inhibitory activity in spontaneously hypertensive rats. Asia Pac. J. Clin. Nutr. 2007, 16, 275-280.
55. Silva-Sanchez, C.; de la Rosa, A.P.; León-Galván, M.F.; de Lumen, B.O.; de León-Rodríguez, A.; de Mejía, E.G. Bioactive peptides in amaranth (Amaranthus hypochondriacus) seed. J. Agric. Food Chem. 2008, 56, 1233-1240.
56. Yano, S.; Suzuki, K.; Funatsu, G. Isolation from alpha-zein of thermolysin peptides with angiotensin I-converting enzyme inhibitory activity. Biosci. Biotechnol. Biochem. 1996, 60, 661-663.
57. Li, H.; Aluko, R.E. Identification and inhibitory properties of multifunctional peptides from pea protein hydrolysate. J. Agric. Food Chem. 2010, 58, 11471-11476.
58. Wu, J.; Aluko, R.E.; Nakai, S. Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure-activity relationship study of di-and tri-peptides. J. Agric. Food Chem. 2006, 54, 732-738.
59. Pak, V.V.; Koo, M.S.; Kasymova, T.D.; Kwon, D.Y. Isolation and identification of peptides from Soy 11S-globulin with hypocholesterolemic activity. Chem. Nat. Compd. 2005, 41, 710-714.
60. Ferreira Ede, S.; Silva, M.A.; Demonte, A.; Neves, V.A. Soy β-conglycinin (7S Globulin) reduces plasma and liver cholesterol in rats fed hypercholesterolemic diet. J. Med. Food 2011, 14, 94-100.
61. Duranti, M.; Lovati, M.R.; Dani, V.; Barbiroli, A.; Scarafoni, A.; Castiglioni, S.; Ponzone, C.; Morazzoni, P. The α' subunit from soybean 7S globulin lowers plasma lipids and upregulates liver β-VLDL receptors in rats fed a hypercholesterolemic diet. J. Nutr. 2004, 134, 1334-1339.
62. Sirtori, C.R.; Lovati, M.R.; Manzoni, C.; Castiglioni, S.; Duranti, M.; Magni, C.; Morandi, S.; D’Agostina, A.; Arnoldi, A. Proteins of white lupin seed, a naturally isoflavone-poor legume, reduce cholesterolemia in rats and increase LDL receptor activity in HepG2 cells. J. Nutr. 2004, 134, 18-23.
63. Wang, W.; de Mejia, E.G. A new frontier in soy bioactive that may prevent age-related chronic diseases. Compr. Rev. Food Sci. Food Saf. 2005, 4, 63-78.
64. Medina-Godoy, S.; Ambriz-Pérez, D.L.; Fuentes-Gutiérrez, C.I.; Germán-Báez, L.J.; Gutiérrez-Dorado, R.; Reyes-Moreno, C.; Valdez-Ortiz, A. Angiotensin-converting enzyme inhibitory and antioxidative activities and functional characterization of protein hydrolysates of hard-to-cook chickpeas. J. Sci. Food Agric. 2012, 92, 1974-1981.
65. Udenigwe, C.C.; Aluko, R.E. Food protein-derived bioactive peptides: Production, processing, and potential health benefits. J. Food Sci. 2012, 77, R11-R24.
66. Kitts, D.D.; Weiler, K. Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Curr. Pharm. Des. 2003, 9, 1309-1323.
67. Tang, X.; Wu, Q.; Le, G.; Wang, J.; Yin, K.; Shi, Y. Structural and antioxidant modification of wheat peptides modified by the heat and lipid peroxidation product malondialdehyde. J. Food Sci. 2012, 77, H16-H22.
68. Chen, H.M.; Muramoto, K.; Yamauchi, F.; Fujimoto, K.; Nokihara, K. Antioxidative properties of histidine-containing peptides designed from peptide fragments found in the digests of a soybean protein. J. Agric. Food Chem. 1998, 46, 49-53.
69. Zhu, K.; Zhou, H.; Quian, H. Antioxidant and free radical-scavenging activities of wheat germ protein hydrolysates (WGPH) prepared with alcalase. Process Biochem. 2006, 41, 1296-1302.
70. Pownall, T.L.; Udenigwe, C.C.; Aluko, R.E. Amino acid composition and antioxidant properties of pea seed (Pisum sativum L.) enzymatic protein hydrolysate fractions. J. Agric. Food Chem. 2010, 58, 4712-4718.
71. Wang, J.; Zhao, M.; Zhao, Q.; Jiang, Y. Antioxidant properties of papain hydrolysates of wheat gluten in different oxidation systems. Food Chem. 2007, 101, 1658-1663.
72. Jeong, J.B.; de Lumen, B.O.; Jeong, H.J. Lunasin peptide purified from Solanum nigrum L. protects DNA from oxidative damage by suppressing the generation of hydroxyl radical via blocking fenton reaction. Cancer Lett. 2010, 293, 58-64.
73. Garcia-Nebot, M.J.; Recio, I.; Hernandez-Ledesma, B. Antioxidant activity and protective effects of peptide lunasin against oxidative stress in intestinal Caco-2 cells. Food Chem. Toxicol. 2014, 65, 155-161.
74. Yin, H.; Pan, X.; Song, Z.; Wang, S.; Yang, L.; Sun, G. Protective effect of wheat peptides against indomethacin-induced oxidative stress in IEC-6 cells. Nutrients 2014, 6, 564-574.
75. García, M.C.; Puchalska, P.; Esteve, C.; Marina, M.L. Vegetable foods: A cheap source of proteins and peptides with antihypertensive, antioxidant, and other less occurrence bioactivities. Talanta 2013, 106, 328-349.
76. Rutherfurd-Markwick, K.J. Food proteins as a source of bioactive peptides with different functions. Br. J. Nutr. 2012, 108, 149-157.
77. Anderson, J.W.; Bush, H.M. Soy protein effects on serum lipoproteins: A quality assessment and meta-analysis of randomized, controlled studies. J. Am. Coll. Nutr. 2011, 30, 79-91.
78. Sirtori, C.R.; Triolo, M.; Bosisio, R.; Bondioli, A.; Calabresi, L.; de Vergori, V.; Gomaraschi, M.; Mombelli, G.; Pazzucconi, F.; Zacherl, C., et al. Hypocholesterolaemic effects of lupin protein and pea protein/fibre combinations in moderately hypercholesterolaemic individuals. Br. J. Nutr. 2012, 107, 1176-1183.
79. Zhu, C.F.; Li, G.Z.; Peng, H.B.; Zhang, F.; Chen, Y.; Li, Y. Treatment with marine collagen peptides modulates glucose and lipid metabolism in Chinese patients with type 2 diabetes mellitus. Appl. Physiol. Nutr. Metab. 2010, 35, 797-804.
80. Cicero, A.F.; Aubin, F.; Azais-Braesco, V.; Borghi, C. Do the lactotripeptides isoleucine-proline-proline and valine-proline-proline reduce systolic blood pressure in European subjects? A meta-analysis of randomized controlled trials. Am. J. Hypertens. 2013, 26, 442-449.
81. Cicero, A.F.; Gerocarni, B.; Laghi, L.; Borghi, C. Blood pressure lowering effect of lactotripeptides assumed as functional foods: A meta-analysis of current available clinical trials. J. Hum. Hypertens. 2011, 25, 425-436.
82. Yoshizawa, M.; Maeda, S.; Miyaki, A.; Misono, M.; Choi, Y.; Shimojo, N.; Ajisaka, R.; Tanaka, H. Additive beneficial effects of lactotripeptides intake with regular exercise on endothelium-dependent dilatation in postmenopausal women. Am. J. Hypertens. 2010, 23, 368-372.
83. Cicero, A.F.; Rosticci, M.; Gerocarni, B.; Bacchelli, S.; Veronesi, M.; Strocchi, E.; Borghi, C. Lactotripeptides effect on office and 24-h ambulatory blood pressure, blood pressure stress response, pulse wave velocity and cardiac output in patients with high-normal blood pressure or first-degree hypertension: A randomized double-blind clinical trial. Hypertens. Res. 2011, 34, 1035-1040.
84. Iwai, K.; Hasegawa, T.; Taguchi, Y.; Morimatsu, F.; Sato, K.; Nakamura, Y.; Higashi, A.; Kido, Y.; Nakabo, Y.; Ohtsuki, K., et al. Identification of food-derived collagen peptides in human blood after oral ingestion of gelatin hydrolysates. J. Agric. Food. Chem. 2005, 53, 6531-6536.
85. Ichikawa, S.; Morifuji, M.; Ohara, H.; Matsumoto, H.; Takeuchi, Y.; Sato, K. Hydroxyproline-containing dipeptides and tripeptides quantified at high concentration in human blood after oral administration of gelatin hydrolysate. Int. J. Food. Sci. Nutr. 2010, 61, 52-60.
86. Shigemura, Y.; Iwai, K.; Morimatsu, F.; Iwamoto, T.; Mori, T.; Oda, C.; Taira, T.; Park, E.Y.; Nakamura, Y.; Sato, K., et al. Effect of Prolyl-hydroxyproline (Pro-Hyp), a food-derived collagen peptide in human blood, on growth of fibroblasts from mouse skin. J. Agric. Food. Chem. 2009, 57, 444-449.
87. Sato, K.; Egashira, Y.; Ono, S.; Mochizuki, S.; Shimmura, Y.; Suzuki Y, Nagata, M.; Hashimoto, K.; Kiyono, T.; Park, E.Y., et al. Identification of a hepatoprotective peptide in wheat gluten hydrolysate against D-galactosamine-induced acute hepatitis in rats. J. Agric. Food Chem. 2013, 61, 6304-6310.